2m 2m 2m 2m 2m 2m 2m
Kura Oncology (KURA)
NASDAQ
$9.01$0.00 (0.00%)
Price as of Jul 31, 2026 7:34 PM EDT- $799.9MMarket Cap
- 49.67%1-Year Change
- BiotechnologyIndustry
Kura Oncology (KURA)
$9.01$0.00 (0.00%)
KURA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.01 | ||
Change | -$0.30 (-3.22%) | ||
Open | $9.46 | ||
High | $9.46 | ||
Low | $8.87 | ||
Previous Close | $9.31 | ||
Volume | 1,169,792 | ||
30-Day Average Volume | 1,439,325 | ||
1-Week Change | -13.28% | ||
1-Month Change | -17.87% | ||
1-Year Change | 49.67% | ||
3-Year Change | -13.70% | ||
5-Year Change | -52.43% | ||
Fundamentals | |||
Shares Outstanding | 88.8M | ||
Total Assets | $652.6M | ||
Market Cap | $799.9M | ||
Enterprise Value | $770.5M | ||
Period: QTR TTM FY | |||
Revenue | $5.8M | ||
Net Income | -$73.3M | ||
Free Cash Flow | -$86.0M | ||
EBIT | -$73.3M | ||
EBITDA | -$73.0M | ||
Net Working Capital | $522.3M | ||
EPS | -$0.83 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 134 | ||
P/B | 7 | ||
P/E | -11 | ||
PEG | -1 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue